Antibacterial activity of three macrofungi, Ganoderma lucidum, Navesporus floccosa and Phellinus rimosus occurring in South India

Pharmaceutical Biology

Volumn 41, Issue 8, 2003, Pages 564-567

  Sheena, N ^a   Ajith, T A ^a   Mathew, A Thomas ^a   Janardhanan, K K ^a  

^a AMALA CANCER RESEARCH CENTRE   (India)

Author keywords

Antibacterial activity; Medicinal mushrooms

Indexed keywords

GANODERMA LUCIDUM EXTRACT; METHANOL EXTRACTION RESIDUE; NAVESPORUS FLOCCOSA EXTRACT; PHELLINUS RIMOSUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL ANALYSIS; FUNGUS; GANODERMA LUCIDUM; INDIA; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; MUSHROOM; NAVESPORUS FLOCCOSA; NONHUMAN; PHELLINUS RIMOSUS; STRAIN DIFFERENCE;

ANIMALIA; BACILLUS SUBTILIS; BASIDIOMYCOTA; ESCHERICHIA COLI; FUNGI; GANODERMA; GANODERMA LUCIDUM; PHELLINUS; PHELLINUS RIMOSUS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 9144255433     PISSN: 13880209     EISSN: None     Source Type: Journal    
DOI: 10.1080/13880200390501226     Document Type: Article

References (15)

1. Ajith TA, Janardhanan KK (2001): Antioxidant and anti-inflammatory activities of methanol extract of Phellinus rimosus (Berk) Pilat. Ind J Exp Bio 39: 1166-1169.
2. Ajith TA, Jose N, Janardhanan KK (2002): Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res 21: 487-491.
3. Ajith TA, Janardhanan KK (2002): Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat. J Ethnopharmacol 81: 387-391.
4. Chang ST (1993): The impact of mushroom production and mushroom products. In: Chang ST, Buswell JA, Chiu SW, eds., Mushroom Biology and Mushroom Products. The Chinese University Press, Hong Kong, pp. 3-20.
5. Coley PD, Aide TM (1991): Comparison of herbivory and plant defenses in temperate and tropical broadleaved forests. In: Price PW, Lewinsohn TM, Fernandes GW, Benson WW, eds., Plant Animal Interations. Wiely, New York, pp. 25-49.
6. Ikekawa T, Naknishi M, Uehera N, Chirara C, Fukuoka F (1968): Antitumor action of some basidiomycetes, especially P linteus Gann 59: 155-157.
7. Jones S, Janardhanan KK (2000): Antioxidant and antitumor activity of Ganoderma lucidum (Curt: Fr.) P. Karst. - Reishi (Aphyllophoromycetideae) from South India. Int J Med Mushr 2: 195-200.
8. Jong SC, Birmingham JM (1992): Edible mushrooms in biotechnology. Proc Asian Mycol Symp. Seoul, Korea, pp. 18-35.
9. Levin DA (1976): Nature Biotechnology. American Naturalist 110: 261-284.
10. Sheena N, Ajith TA, Janardhanan KK (2003): Anti-inflammatory and anti-nociceptive activities of Ganoderma lucidum occurring in South India. Pharm Biol 41: 301-304.
11. Shiao MS, Lee KK, Lin LJ, Wang CT (1994): Natural products and biological activities of the Chinese medicinal fungus Ganoderma lucidum. In: Ho CT, Osawa T, Huang MT, Roem RT, eds., Food Phytochemicals II: Teas, Spices and Herbs. American Chem Society, Washington DC, pp. 342-354.
12. Suffness M, Douros J (1979): Drugs of plant origin. In: Devita VT JR, Busch H, eds., Methods in Cancer Research, Academic Press, New York, Vol. XVI, pp. 73-126.
13. Wagner H, Bladt S, Zgairski EM (1984): Plant Drug Analysis, Springer-Verlag, Berling/New York, pp. 304-310.
14. Wasser SP, Weis AL (1999): Medicinal properties of substances occurring in higher basidiomycetes mushrooms: Current perspectives (Review). Int J Med Mushr 1: 31-62.
15. Ying JZ, Mao XL, Ma QM, Zong SC, Wen HA (1987): Illustrations of Chinese Medicinal Fungi, Science Press, Beijing, pp. 579-582.